{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T21:08:20Z","timestamp":1788469700133,"version":"build-2803163510"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,8,28]],"date-time":"2015-08-28T00:00:00Z","timestamp":1440720000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Funda\u00e7\u00e3o de Amparo a Pesquisa do Estado de S\u00e3o Paulo (FAPESP)"},{"name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico (CNPq)"},{"name":"Coordenadoria de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior (CAPES)"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.redox.2015.08.017","type":"journal-article","created":{"date-parts":[[2015,8,31]],"date-time":"2015-08-31T13:31:19Z","timestamp":1441027879000},"page":"386-395","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Atorvastatin and sildenafil decrease vascular TGF-\u03b2 levels and MMP-2 activity and ameliorate arterial remodeling in a model of renovascular hypertension"],"prefix":"10.1016","volume":"6","author":[{"given":"Danielle A.","family":"Guimar\u00e3es","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elen","family":"Rizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla S.","family":"Ceron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisson","family":"Martins-Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel F.","family":"Gerlach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sruti","family":"Shiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose E.","family":"Tanus-Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.redox.2015.08.017_bib1","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.cardiores.2005.11.026","article-title":"Vascular remodeling and protease inhibition \u2013 bench to bedside","volume":"69","author":"Sluijter","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.redox.2015.08.017_bib2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/sj.bjp.0707344","article-title":"Acute actions and novel targets of matrix metalloproteinases in the heart and vasculature","volume":"152","author":"Chow","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.redox.2015.08.017_bib3","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1742-7843.2011.00698.x","article-title":"Consistent alterations of circulating matrix metalloproteinases levels in untreated hypertensives and in spontaneously hypertensive rats: a relevant pharmacological target","volume":"109","author":"Fontana","year":"2011","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.redox.2015.08.017_bib4","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1161\/01.ATV.0000151373.33830.41","article-title":"Matrix metalloproteinase-9 (MMP-9), MMP-2, and serum elastase activity are associated with systolic hypertension and arterial stiffness","volume":"25","author":"Yasmin","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.redox.2015.08.017_bib5","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.atherosclerosis.2007.10.011","article-title":"Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats","volume":"198","author":"Castro","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.redox.2015.08.017_bib6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1476-5381.2010.00678.x","article-title":"Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase-2 activity and expression in a model of renovascular hypertension","volume":"160","author":"Ceron","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.redox.2015.08.017_bib7","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.ijcard.2012.03.137","article-title":"Contrasting effects of aliskiren versus losartan on hypertensive vascular remodeling","volume":"167","author":"Martins-Oliveira","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.redox.2015.08.017_bib8","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1161\/01.ATV.0000225777.58488.f2","article-title":"Matrix metalloproteinase 2 activation of transforming growth factor-beta1 (TGF-beta1) and TGF-beta1-type II receptor signaling within the aged arterial wall","volume":"26","author":"Wang","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.redox.2015.08.017_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2009.09.026","article-title":"Oxidative stress and glutathione in TGF-beta-mediated fibrogenesis","volume":"48","author":"Liu","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2015.08.017_bib10","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1096\/fj.03-1273rev","article-title":"TGF-beta signaling and the fibrotic response","volume":"18","author":"Leask","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.redox.2015.08.017_bib11","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/sj.jcbfm.9600116","article-title":"Statins and stroke","volume":"25","author":"Endres","year":"2005","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.redox.2015.08.017_bib12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.molmed.2007.11.004","article-title":"Pleiotropic effects of statin therapy: molecular mechanisms and clinical results","volume":"14","author":"Wang","year":"2008","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.redox.2015.08.017_bib13","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1161\/CIRCULATIONAHA.112.094912","article-title":"Is inhibition of phosphodiesterase type 5 by sildenafil a promising therapy for volume-overload heart failure?","volume":"125","author":"Dai","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.redox.2015.08.017_bib14","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00210-011-0623-0","article-title":"Effects of statins on matrix metalloproteinases and their endogenous inhibitors in human endothelial cells","volume":"383","author":"Izidoro-Toledo","year":"2011","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.redox.2015.08.017_bib15","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1161\/01.ATV.0000068646.76823.AE","article-title":"Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophages","volume":"23","author":"Luan","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.redox.2015.08.017_bib16","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1161\/HYPERTENSIONAHA.107.091264","article-title":"HMG-CoA reductase inhibitors decrease angiotensin II-induced vascular fibrosis: role of RhoA\/ROCK and MAPK pathways","volume":"50","author":"Ruperez","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.redox.2015.08.017_bib17","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ejphar.2006.04.039","article-title":"Sildenafil reduces cardiovascular remodeling associated with hypertensive cardiomyopathy in NOS inhibitor-treated rats","volume":"542","author":"Ferreira-Melo","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.redox.2015.08.017_bib18","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.thromres.2008.12.006","article-title":"Nitrite or sildenafil, but not BAY 41-2272, blunt acute pulmonary embolism-induced increases in circulating matrix metalloproteinase-9 and oxidative stress","volume":"124","author":"Dias-Junior","year":"2009","journal-title":"Thromb. Res."},{"key":"10.1016\/j.redox.2015.08.017_bib19","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1159\/000343414","article-title":"Renoprotective effects of sildenafil in DOCA-salt hypertensive rats","volume":"36","author":"Bae","year":"2012","journal-title":"Kidney Blood Press Res."},{"key":"10.1016\/j.redox.2015.08.017_bib20","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ejphar.2011.09.018","article-title":"Sildenafil improves the beneficial hemodynamic effects exerted by atorvastatin during acute pulmonary thromboembolism","volume":"670","author":"Neto-Neves","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.redox.2015.08.017_bib21","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/PHM.0b013e3182643f1a","article-title":"Efficacy of combined atorvastatin and sildenafil in promoting recovery after ischemic stroke in mice","volume":"92","author":"Wang","year":"2013","journal-title":"Am. J. Phys. Med. Rehabil."},{"key":"10.1016\/j.redox.2015.08.017_bib22","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ejphar.2004.07.051","article-title":"Atorvastatin enhances sildenafil-induced vasodilation through nitric oxide-mediated mechanisms","volume":"498","author":"Castro","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.redox.2015.08.017_bib23","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1083\/jcb.50.1.172","article-title":"The smooth muscle cell. II. Growth of smooth muscle in culture and formation of elastic fibers","volume":"50","author":"Ross","year":"1971","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.redox.2015.08.017_bib24","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1161\/CIRCULATIONAHA.109.891077","article-title":"Nitrite potently inhibits hypoxic and inflammatory pulmonary arterial hypertension and smooth muscle proliferation via xanthine oxidoreductase-dependent nitric oxide generation","volume":"121","author":"Zuckerbraun","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.redox.2015.08.017_bib25","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1161\/01.HYP.37.6.1450","article-title":"HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species","volume":"37","author":"Wassmann","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.redox.2015.08.017_bib26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.freeradbiomed.2013.06.033","article-title":"Nebivolol attenuates prooxidant and profibrotic mechanisms involving TGF-beta and MMPs, and decreases vascular remodeling in renovascular hypertension","volume":"65","author":"Ceron","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2015.08.017_bib27","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.clinbiochem.2005.02.010","article-title":"Methodological issues affecting the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities","volume":"38","author":"Souza-Tarla","year":"2005","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.redox.2015.08.017_bib28","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.freeradbiomed.2009.02.011","article-title":"Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension","volume":"46","author":"Castro","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2015.08.017_bib29","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jbiotec.2011.09.030","article-title":"Expression of soluble and functional full-length human matrix metalloproteinase-2 in Escherichia coli","volume":"157","author":"Goncalves","year":"2012","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.redox.2015.08.017_bib30","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/S0895-7061(98)00124-1","article-title":"Increased plasma levels of platelet-derived growth factor (PDGF-BB+PDGF-AB) in patients with never-treated mild essential hypertension","volume":"11","author":"Rossi","year":"1998","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.redox.2015.08.017_bib31","doi-asserted-by":"crossref","first-page":"21926","DOI":"10.1074\/jbc.274.31.21926","article-title":"3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors attenuate vascular smooth muscle proliferation by preventing rho GTPase-induced down-regulation of p27(Kip1)","volume":"274","author":"Laufs","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2015.08.017_bib32","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00395-004-0504-5","article-title":"Antiproliferative effect of sildenafil on human pulmonary artery smooth muscle cells","volume":"100","author":"Tantini","year":"2005","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.redox.2015.08.017_bib33","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1536\/ihj.51.426","article-title":"Atorvastatin prevents left ventricular remodeling in spontaneously hypertensive rats","volume":"51","author":"Zhao","year":"2010","journal-title":"Int. Heart J."},{"key":"10.1016\/j.redox.2015.08.017_bib34","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nm1175","article-title":"Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy","volume":"11","author":"Takimoto","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.redox.2015.08.017_bib35","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.matbio.2012.01.009","article-title":"Time course involvement of matrix metalloproteinases in the vascular alterations of renovascular hypertension","volume":"31","author":"Ceron","year":"2012","journal-title":"Matrix Biol."},{"key":"10.1016\/j.redox.2015.08.017_bib36","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00109-013-1111-4","article-title":"Overexpression of SIRT1 in vascular smooth muscle cells attenuates angiotensin II-induced vascular remodeling and hypertension in mice","volume":"92","author":"Gao","year":"2014","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.redox.2015.08.017_bib37","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1165\/rcmb.2010-0052OC","article-title":"The mevalonate cascade as a target to suppress extracellular matrix synthesis by human airway smooth muscle","volume":"44","author":"Schaafsma","year":"2011","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.redox.2015.08.017_bib38","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1161\/HYPERTENSIONAHA.109.133710","article-title":"Atorvastatin prevents angiotensin II-induced vascular remodeling and oxidative stress","volume":"54","author":"Briones","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.redox.2015.08.017_bib39","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.phrs.2011.04.002","article-title":"Matrix metalloproteinases: targets for doxycycline to prevent the vascular alterations of hypertension","volume":"64","author":"Castro","year":"2011","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.redox.2015.08.017_bib40","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1476-5381.2011.01360.x","article-title":"Pyrrolidine dithiocarbamate down-regulates vascular matrix metalloproteinases and ameliorates vascular dysfunction and remodelling in renovascular hypertension","volume":"164","author":"Cau","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.redox.2015.08.017_bib41","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1742-7843.2010.00656.x","article-title":"Doxycycline dose-dependently inhibits MMP-2-mediated vascular changes in 2K1C hypertension","volume":"108","author":"Guimaraes","year":"2011","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.redox.2015.08.017_bib42","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.redox.2013.11.004","article-title":"Atorvastatin and sildenafil lower blood pressure and improve endothelial dysfunction, but only atorvastatin increases vascular stores of nitric oxide in hypertension","volume":"1","author":"Guimaraes","year":"2013","journal-title":"Redox Biol."},{"issue":"III","key":"10.1016\/j.redox.2015.08.017_bib43","first-page":"39","article-title":"Beneficial cardiovascular pleiotropic effects of statins","volume":"109","author":"Davignon","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.redox.2015.08.017_bib44","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1161\/01.CIR.97.12.1129","article-title":"Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors","volume":"97","author":"Laufs","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.redox.2015.08.017_bib45","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.amjmed.2012.08.015","article-title":"Phosphodiesterase type 5 inhibitors improve endothelial function and may benefit cardiovascular conditions","volume":"126","author":"Schwartz","year":"2013","journal-title":"Am. J. Med."},{"key":"10.1016\/j.redox.2015.08.017_bib46","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0026-895X(24)12257-2","article-title":"Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac1 GTPase","volume":"59","author":"Wassmann","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.redox.2015.08.017_bib47","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1631\/jzus.2003.0612","article-title":"Effects of atorvastatin on vascular remodeling in spontaneously hypertensive rats","volume":"4","author":"Ge","year":"2003","journal-title":"J. Zhejiang Univ. Sci."},{"key":"10.1016\/j.redox.2015.08.017_bib48","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/sj.bjp.0707131","article-title":"Sildenafil reduces l-NAME-induced severe hypertension and worsening of myocardial ischaemia\u2013reperfusion damage in the rat","volume":"150","author":"Rossoni","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.redox.2015.08.017_bib49","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/jhh.2011.80","article-title":"Low-dose atorvastatin reduces ambulatory blood pressure in patients with mild hypertension and hypercholesterolaemia: a double-blind, randomized, placebo-controlled study","volume":"26","author":"Kanaki","year":"2012","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.redox.2015.08.017_bib50","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1161\/01.HYP.0000239816.13007.c9","article-title":"Effect of regular phosphodiesterase type 5 inhibition in hypertension","volume":"48","author":"Oliver","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.redox.2015.08.017_bib51","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1006\/jsre.1996.0138","article-title":"Effect of histologic preparation on the cross-sectional area of arterial rings","volume":"61","author":"Dobrin","year":"1996","journal-title":"J. Surg. Res."}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221323171500107X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221323171500107X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T06:02:10Z","timestamp":1761976930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221323171500107X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":51,"alternative-id":["S221323171500107X"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2015.08.017","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atorvastatin and sildenafil decrease vascular TGF-\u03b2 levels and MMP-2 activity and ameliorate arterial remodeling in a model of renovascular hypertension","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2015.08.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}